Back to HRTX
GOLDMAN SACHS GROUP INC → HRTX
GOLDMAN SACHS GROUP INC HRTX Position History
Heron Therapeutics, Inc. • Healthcare
Quarters held
26
Latest value
$274K
Q3 2026
Peak value
$1.5M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $543K |
| Q2 2025 | $1.5M |
| Q2 2025 | $27K |
| Q2 2025 | $66K |
| Q2 2025 | $40K |
| Q3 2025 | $906K |
| Q3 2025 | $690K |
| Q3 2025 | $56K |
| Q3 2025 | $17K |
| Q4 2025 | $56K |
| Q4 2025 | $17K |
| Q4 2025 | $946K |
| Q4 2025 | $268K |
| Q4 2025 | $268K |
| Q4 2025 | $946K |
| Q4 2025 | $17K |
| Q4 2025 | $56K |
| Q1 2026 | $228K |
| Q1 2026 | $583K |
| Q1 2026 | $10K |
| Q1 2026 | $25K |
| Q2 2026 | $75K |
| Q2 2026 | $488K |
| Q2 2026 | $4K |
| Q3 2026 | $121K |
| Q3 2026 | $274K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $274K | 874.2K | — | — |
| Q3 2026 | $121K | 384.4K | — | — |
| Q2 2026 | $4K | 10.2K | — | — |
| Q2 2026 | $488K | 1.14M | — | — |
| Q2 2026 | $75K | 175.2K | — | — |
| Q1 2026 | $25K | 31.7K | — | — |
| Q1 2026 | $10K | 12.6K | — | — |
| Q1 2026 | $583K | 728.1K | — | — |
| Q1 2026 | $228K | 284.6K | — | — |
| Q4 2025 | $56K | 42.9K | — | — |
| Q4 2025 | $17K | 13.4K | — | — |
| Q4 2025 | $946K | 727.7K | — | — |
| Q4 2025 | $268K | 205.8K | — | — |
| Q4 2025 | $268K | 205.8K | — | — |
| Q4 2025 | $946K | 727.7K | — | — |
| Q4 2025 | $17K | 13.3K | — | — |
| Q4 2025 | $56K | 42.9K | — | — |
| Q3 2025 | $17K | 13.6K | — | — |
| Q3 2025 | $56K | 44.4K | — | — |
| Q3 2025 | $690K | 547.7K | — | — |
| Q3 2025 | $906K | 719.0K | — | — |
| Q2 2025 | $40K | 19.4K | — | — |
| Q2 2025 | $66K | 31.9K | — | — |
| Q2 2025 | $27K | 13.2K | — | — |
| Q2 2025 | $1.5M | 716.6K | — | — |
| Q2 2025 | $543K | 262.2K | — | — |